Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1324.3552.8 (+4.15 %)

PREV CLOSE ( ) 1271.55

OPEN PRICE ( ) 1288.90

BID PRICE (QTY) 1320.45 (263)

OFFER PRICE (QTY) 1322.55 (20)

VOLUME 80442

TODAY'S LOW / HIGH ( )1285.05 1349.70

52 WK LOW / HIGH ( )987.05 2149.9

NSE1321.0048.8 (+3.84 %)

PREV CLOSE( ) 1272.20

OPEN PRICE ( ) 1284.00

BID PRICE (QTY) 1320.20 (14)

OFFER PRICE (QTY) 1321.00 (8)

VOLUME 1117970

TODAY'S LOW / HIGH( ) 1282.60 1349.90

52 WK LOW / HIGH ( )987 2150.4

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

3260.8

2777.66

2470.58

2039.88

Total Expenditure

2075.48

1787.86

1585.67

1425.9

PBIDT (Excl OI)

1185.32

989.8

884.91

613.98

Other Income

153.49

99.76

133.52

136.78

Operating Profit

1338.81

1089.56

1018.43

750.75

Interest

0.84

0.82

0.59

Exceptional Items

-32.75

PBDT

1337.97

1055.99

1017.84

750.16

Depreciation

195.44

187.47

183.92

177.76

Profit Before Tax

1142.53

868.52

833.92

572.4

Tax

256.08

225.14

226.21

146.74

Provisions and contingencies

Profit After Tax

886.45

643.38

607.71

425.66

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

886.45

643.38

607.71

425.66

Minority Interest

3.24

8.35

5.18

Shares of Associates

-1.78

-6.97

22.91

14.92

Other related items

Misc. Expenses Written off

Consolidated Net Profit

887.9

644.77

635.81

440.58

Equity Capital

104.62

Face Value (IN RS)

Reserves

Calculated EPS

8.48

6.16

6.07

4.21

Calculated EPS (Annualised)

33.94

24.65

24.30

16.84

No of Public Share Holdings

58499596

% of Public Share Holdings

55.92

PBIDTM% (Excl OI)

36.35

35.63

35.81

30.09

PBIDTM%

41.05

39.22

41.22

36.80

PBDTM%

41.03

38.01

41.19

36.77

PBTM%

35.03

31.26

33.75

28.06

PATM%

27.18

23.16

24.59

20.86

Notes

Risk Disclosures on Derivatives

Quarterly Results

CONCORD BIOTECH LTD.